Management of Parkinson Disease in 2017 Personalized Approaches for Patient-Specific Needs

Published: September 7th, 2017

Category: Slider Pages

The approach and treatment of Parkinson disease is perpetually changing for a better management of a multitude of associated motor (tremors, stiffness, slowness, gait) and non-motor (sleep disturbances, mood disorders, drooling) symptoms. Dr. Michael Okun, Chief of UF’s Department of Neuorlogy, has recently published a viewpoint article in the Journal of the American Medical Association (JAMA) discussing the management of Parkinson disease in 2017.

Dr. Okun discussed the importance of multidisciplinary and patient-centered care. He eloquently presented the different medications available as well as the more advanced therapies, such as deep brain stimulation and infusion pumps. He summarized the state-of-the-evidence approach to treatment such as the first choice of medication for Parkinson disease, the role of levodopa, and the management of therapy complications.

To read the full article click here.